EW vs PPCB · P/E 47, rev $1.39B vs P/E 0.0, $3.9M cap
Edwards Lifesciences Corp (EW) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
PPCB does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the EW and PPCB stock pages for the full models.
Not investment advice.